Clinical and prognostic significance of eosinophilia and inv(16)/t(16;16) in pediatric acute myelomonocytic leukemia (AML‐M4)
Authors:
- 30 March 2017
- journal article
- research article
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 64 (10)
Abstract
Background: The cytogenetic aberrations inv(16)(p13.1q22)/t(16;16)(p13.1;q22), frequently detected in acute myelomonocytic leukemia with eosinophilia (FAB type M4eo), are generally considered a prognostically favorable subgroup. M4eo comprises a distinct morphology compared to M4 without eosinophilia (M4eo‐) and therefore may be indicative for a different pathogenesis.Procedures: Morphology and cytogenetic/molecular analyses of a Dutch cohort of pediatric acute myelomonocytic leukemia (AML‐M4) patients were performed and studied in order to analyze the association between the presence of eosinophilia morphology (M4eo+), inv(16)/t(16;16) (inv(16)+), clinical features, and outcome.Results: Of the 119 included patients with available combined morphological and cytogenetic results, 60% had M4eo‐ without inv(16) (inv(16)‐), 10% had M4eo‐/inv(16)+, 13% had M4eo+/inv(16)‐, and 17% had M4eo+/inv(16)+. M4eo+ was significantly associated with the presence of inv(16)/t(16;16) (P < 0.001). Patients with M4eo+ had no significantly superior outcome compared with patients with M4eo‐, whereas patients with inv(16)+ had significantly superior probabilities of event‐free survival and probabilities of overall survival compared with patients without inv(16)‐. Patients with M4eo+/inv(16)+ had no significantly better outcome than those with M4eo‐/inv(16)+.Conclusion: The prognostically favorable impact of distinct morphology with eosinophilia probably relies on its association with inv(16)/t(16;16). Simultaneous presence of both eosinophilia and inv(16) was not associated with superior outcome in our study. These results may be relevant for risk‐group classification and risk‐group adapted treatment and underline the importance of accurate cytogenetic analysis.Keywords
Funding Information
- DCOG
- Dutch VONK
This publication has 23 references indexed in Scilit:
- The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemiaBlood, 2016
- Collaborative Efforts Driving Progress in Pediatric Acute Myeloid LeukemiaJournal of Clinical Oncology, 2015
- Results of the AIEOP AML 2002/01 multicenter prospective trial for the treatment of children with acute myeloid leukemiaBlood, 2013
- Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panelBlood, 2012
- Outcome in 146 patients with paediatric acute myeloid leukaemia treated according to the AML99 protocol in the period 2003–06 from the Japan Association of Childhood Leukaemia StudyBritish Journal of Haematology, 2012
- Pediatric acute myeloid leukemia: international progress and future directionsLeukemia, 2005
- Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML‐MO)British Journal of Haematology, 1991
- Prognostische Bedeutung der Eosinophilie bei Kindern mit akuter myeloischer Leukämie in den Studien AML-BFM-78 und -83*Klinische Padiatrie, 1989
- Proposed Revised Criteria for the Classification of Acute Myeloid LeukemiaAnnals of Internal Medicine, 1985
- Criteria for the Diagnosis of Acute Leukemia of Megakaryocyte Lineage (M7)Annals of Internal Medicine, 1985